MedTrace Logo

Bacteremia

Disease

Related News

Eledon Pharmaceuticals Presents Long-Term Phase 2 BESTOW Data Showing Tegoprubart Benefits Over Tacrolimus in Kidney Transplant

Eledon Pharmaceuticals reported positive long-term Phase 2 BESTOW trial results for tegoprubart in kidney transplant, showing sustained kidney function benefits and improved patient outcomes versus tacrolimus. The company outlined plans for a Phase 3 registrational trial and seeks an FDA meeting in early 2027. Safety data indicated lower adverse event rates with tegoprubart.

Cardinal Health Recalls Alcohol Prep Pads Over Bacterial Contamination Risk

Cardinal Health has recalled certain lots of Webcol Large Alcohol Prep Pads due to potential contamination with Paenibacillus phoenicis bacteria. The affected pads were distributed between September 2025 and February 2026 and pose infection risks, particularly for immunocompromised individuals. The FDA is aware of the voluntary recall.

Related Clinical Trials

NCT ID Title Status Phase
NCT07486362

Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge

 COMPLETED
NCT07240077

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

 RECRUITING PHASE4
NCT07082465

Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand

 ACTIVE_NOT_RECRUITING
NCT06821282

Surveillance of AMR in DRC

 RECRUITING
NCT05721781

Reducing Risk for Infective Endocarditis

 RECRUITING NA
NCT05521880

Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use

 TERMINATED PHASE4
NCT02417168

Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study

 TERMINATED